Welcome to Cato Research - a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.
Press Releases
-
April 29th, 2008 - Duska Therapeutics and Cato Research plan 505(b)(2) NDA filing route for ATPace â„¢
-
April 3rd, 2008 - Cato Research and Advanced Targeting Systems Inc. Partner to Develop SP-SAP for Chronic Pain
-
March 13th, 2008 - Cato Research and Duska Therapeutics Plan Meeting with the FDA on ATPace
- More...
